| Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer? MZ Kocak, M Er, M Ugrakli, E Hendem, M Araz, MK Eryilmaz, M Artac European Journal of Clinical Pharmacology 79 (4), 485-491, 2023 | 3 | 2023 |
| Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer S Kahraman, E Erul, M Seyyar, O Gumusay, E Bayram, BC Demirel, ... Future Oncology 19 (10), 727-736, 2023 | 3 | 2023 |
| First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer SA Esen, Y Ergun, C Erol, R Arikan, MM Er, MM Atci, A Topçu, G Uçar, ... Bosnian journal of basic medical sciences 22 (5), 818, 2022 | 3 | 2022 |
| Ribociclib-induced hepatotoxicity MM Er, M Araz, E Hendem, MK Eryılmaz, M Artaç Journal of Oncology Pharmacy Practice 29 (5), 1275-1277, 2023 | 2 | 2023 |
| Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy? M Korkmaz, MK Eryılmaz, MM Er, MZ Koçak, A Demirkıran, M Karaağaç, ... Journal of Gastrointestinal Cancer 54 (3), 962-969, 2023 | 1 | 2023 |
| Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine … M Korkmaz, MK Eryılmaz, MZ Koçak, ME Muhammed, E Hendem, ... Journal of Cancer Research and Therapeutics 19 (Suppl 1), S160-S165, 2023 | 1 | 2023 |
| Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor MM Er, M Araz, M Karabacak, M Uğraklı, MK Eryılmaz, M Karaağaç, ... Journal of Oncology Pharmacy Practice 27 (8), 2049-2052, 2021 | 1 | 2021 |
| The impact of the COVID-19 pandemic on follow-up and management of cancer patients MK ERYILMAZ, M KARAAĞAÇ, MZ KOÇAK, M KORKMAZ, M UĞRAKLI, ... Journal of oncological sciences 7 (3), 98-105, 2021 | 1 | 2021 |
| Konya ilindeki erişkin çölyak hastalarının epidemiyolojik, klinik ve laboratuvar bulgularının retrospektif olarak değerlendirilmesi MM Er Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, 2018 | 1 | 2018 |
| The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in … M Korkmaz, MK Eryılmaz, MZ Koçak, MM Er, E Hendem, A Demirkıran, ... European Journal of Clinical Pharmacology 80 (6), 941-947, 2024 | | 2024 |
| Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases S Kahraman, S Karakaya, MA Kaplan, SS Goksu, A Ozturk, ZS Isleyen, ... Scientific Reports 14 (1), 5820, 2024 | | 2024 |
| The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study M Uğraklı, MZ Koçak, G Dinç, TB Genç, M Çağlayan, S Uğraklı, E Hendem, ... Journal of Cancer Research and Clinical Oncology 149 (11), 9183-9189, 2023 | | 2023 |
| Ribociclib-Induced Acute Pancreatitis in Metastatic Breast Cancer M Ugrakli, MK Eryilmaz, M Asil, U Kerimoglu, E Hendem, MM Er, ... | | 2022 |
| KONYA İLİNDEKİ ERİŞKİN ÇÖLYAK HASTALARININ EPİDEMİYOLOJİK, KLİNİK VE LABORATUVAR BULGULARININ RETROSPEKTİF OLARAK DEĞERLENDİRİLMESİ MM Er, A Demir Ege Tıp Bilimleri Dergisi 4 (3), 79-83, 2021 | | 2021 |
| JOURNAL of ONCOLOGICAL SCIENCES MK ERYILMAZ, M KARAAĞAÇ, MZ KOÇAK, M KORKMAZ, M UĞRAKLI, ... | | |
| Ribociclib-Induced Acute Pancreatitis in Metastatic Breast Cancer M Uğraklı, M Karakurt Eryılmaz, M Asıl, Ü Kerimoğlu, E Hendem, MM Er, ... EURASIAN JOURNAL OF MEDICAL ADVANCES 2 (3), 148-153, 0 | | |
